抗精神病药血脑屏障区域性与亚区域非结合转运的神经药代动力学可视化
该研究将体内与体外神经药代动力学研究与质谱成像相结合,在20微米分辨率下量化和可视化抗精神病药利培酮、氯氮平和奥氮平在小脑区区域与亚区域的非结合血脑屏障转运及屏障后脑内分布。该方法可区分其他手段无法实现的区域与亚区域血脑屏障转运特征,有助于解释区域靶点暴露结果并辅助决策。
要点
- 结合体内外神经药代动力学与质谱成像可量化非结合药物血脑屏障转运。
- 在20微米分辨率下可视化利培酮、氯氮平和奥氮平的区域与亚区域脑内分布。
- 该方法可区分小脑区区域与亚区域血脑屏障转运异质性。
核心结论
- 融合体内外神经药代动力学与质谱成像的方法可量化和可视化非结合抗精神病药的血脑屏障转运及屏障后区域与亚区域脑内分布。
- 该方法在20微米分辨率下可区分小脑区区域与亚区域血脑屏障转运特征,为其他手段所不能及。
研究设计与样本
- 研究采用体内与体外神经药代动力学研究结合质谱成像的方法。
- 研究对象为抗精神病药利培酮、氯氮平和奥氮平。
主要发现
- 直接成像利培酮、氯氮平和奥氮平可在20微米分辨率下区分小脑区区域与亚区域血脑屏障转运特征。
- 该方法可揭示血脑屏障转运的异质性。
临床怎么用
- 该方法有助于分子精神病学家解释区域靶点部位暴露结果并辅助决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Comprehensive determination of the extent of drug transport across the region-specific blood-brain barrier (BBB) is a major challenge in preclinical studies. Multiple approaches are needed to determine the regional free (unbound) drug concentration at which a drug engages with its therapeutic target. We present an approach that merges in vivo and in vitro neuropharmacokinetic investigations with mass spectrometry imaging to quantify and visualize both the extent of unbound drug BBB transport and the post-BBB cerebral distribution of drugs at regional and subregional levels. Direct imaging of the antipsychotic drugs risperidone, clozapine, and olanzapine using this approach enabled differentiation of regional and subregional BBB transport characteristics at 20-µm resolution in small brain regions, which could not be achieved by other means. Our approach allows investigation of heterogeneity in BBB transport and presents new possibilities for molecular psychiatrists by facilitating interpretation of regional target-site exposure results and decision-making.
引用
- Luptáková D, Vallianatou T, Nilsson A, et al. Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood-brain barrier. Mol Psychiatry. 2021. PMID: 34480089. doi:10.1038/s41380-021-01267-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。